TG Therapeutics | TGTX - Umlaufvermögen





Umlaufvermögen Veränderung Datum
AbbVie USD 33.53B 4.47B 2026-03
Alaunos Therapeutics USD 970K 1.02M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Ardelyx USD 381.87M 447K 2026-03
Arrowhead Research USD 1.84B 665.36M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Biogen USD 7.31B 1.88B 2026-06
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Curis USD 6.92M 7.5M 2025-12
Gilead Sciences USD 18.64B 1.25B 2026-03
J&J USD 59.77B 601M 2026-06
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Novartis USD 27.35B 744M 2026-06
Novavax USD 850.82M 127.46M 2026-03
PTC Therapeutics USD 2.62B 363.36M 2026-06
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.45B 236.8M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
TG Therapeutics USD 1.09B 456.2M 2026-03
Verastem USD 223.41M 69.36M 2025-12
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03